News & Insights

In Psychology Today, Dr. Anton C. Bizzell discusses how mental health was impacted throughout 2020 because of COVID-19. Once COVID-19 took hold worldwide early last year, its mental health effects...
The Bizzell Group (Bizzell) continues to lead in their commitment to improving lives globally, including some of the most vulnerable children in developing countries. Bizzell recently donated water tanks and sinks for young children...
On BYU Radio’s The Lisa Show, Dr. Anton C. Bizzell offers his advice on coping with the holiday blues. The holidays can be one of the happiest seasons—but they can also be...
On a recent episode of Recovery Radio, Dr. Bizzell discusses his experiences working with state and local chambers of commerce and individual businesses on the opioid epidemic and offers his advice for...
In his recent article in Behavioral Healthcare Executive, “Stopping the ‘Other’ Surge: Addressing Rise in OUD Rates Amid Pandemic,” Dr. Anton C. Bizzell discusses how patients and their healthcare partners are...
In a Psychology Today article, “Coping With Holiday Blues During COVID-19,” Dr. Anton C. Bizzell focuses on how to cope with holiday blues during COVID-19, including tips for recognizing and managing your...
Jenny Twesten, MPH, Project Director of the National Cancer Institute, Tobacco Control Research Branch contract, co-authored a manuscript in the November issue of Nicotine & Tobacco Research (NTR) that was selected as an Editor’s Choice submission.
Mark Stewart, MPH, Senior Associate of Health Systems and Services, is an author on an in-press manuscript in The Journal of the Post-Acute and Long-Term Care Medicine (JAMDA). The article details...
Dr. Anton C. Bizzell underscores in Psychology Today how The Bizzell Group (Bizzell) helps preserve the mental wellness of our healthcare heroes. People often choose...
In a recent U.S. Chamber of Commerce Foundation (USCCF) blog post, “How Forward-Looking Companies Can Address the Signs of Mental Health Decline in the Workplace,” Dr. Anton C. Bizzell discusses how business leaders can...
Dr. Anton C. Bizzell shares his insights in the Verywell Health article, “Regeneron Earns First-Ever FDA Approval For Ebola Treatment,” about the U.S. Food and Drug Administration (FDA) approval of Inmazeb, an antibody cocktail designed to...
In a recent Psychology Today article, Dr. Anton C. Bizzell highlights some of the lessons The Bizzell Group (Bizzell) learned during the most recent Ebola virus epidemic. Bizzell partnered with...